Recurrent glioblastomas with very few mutations are far more vulnerable to immunotherapies
Glioblastoma brain tumors are particularly anxious. Inevitably fatal, the tumors occasionally respond to new immunotherapies after they grow back, allowing up to 20% of patients to survive well bey…
